HLA associations and Löfgren’s syndrome

References

• Franke A, Fischer A, Nothnagel M et al. Genome-wide association analysis in sarcoidosis and Crohn’s disease unravels a common susceptibility locus on 10p12.2. Gastroenterology135(4), 1207–1215 (2008).
   PubMedGoogle Scholar
• Hofmann S, Franke A, Fischer A et al. Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat. Genet. (2008).
   PubMedGoogle Scholar
• Iannuzzi MC. Genetics of sarcoidosis. Semin. Respir. Crit. Care Med.28(1), 15–21 (2007).
   PubMed Web of Science ®Google Scholar
• Iannuzzi MC, Iyengar SK, Gray-McGuire C et al. Genome-wide search for sarcoidosis susceptibility genes in African–Americans. Genes Immun.6(6), 509–518 (2005).
   PubMedGoogle Scholar
• Iannuzzi MC, Rybicki BA. Genetics of sarcoidosis: candidate genes and genome scans. Proc. Am. Thorac. Soc.4(1), 108–116 (2007).
   PubMedGoogle Scholar
• Rybicki BA, Levin AM, McKeigue P et al. A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans. Genes Immun.12(2), 67–77 (2011).
   PubMedGoogle Scholar
• Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E. Results from a genome-wide search for predisposing genes in sarcoidosis. Am. J. Respir. Crit. Care Med.164(5), 840–846 (2001).
   PubMed Web of Science ®Google Scholar
• Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR. Selective activation and accumulation of oligoclonal V β-specific T cells in active pulmonary sarcoidosis. J. Clin. Invest.94(4), 1533–1542 (1994).
   PubMed Web of Science ®Google Scholar
• Grunewald J, Janson CH, Eklund A et al. Restricted V α 2.3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR3. Eur. J. Immunol.22(1), 129–135 (1992).
   PubMed Web of Science ®Google Scholar
• Grunewald J, Olerup O, Persson U, Ohrn MB, Wigzell H, Eklund A. T-cell receptor variable region gene usage by CD4+ and CD8+ T cells in bronchoalveolar lavage fluid and peripheral blood of sarcoidosis patients. Proc. Natl Acad. Sci. USA91(11), 4965–4969 (1994).
   PubMed Web of Science ®Google Scholar
• Moller DR. T-cell receptor genes in sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis.15(2), 158–164 (1998).
   PubMedGoogle Scholar
• Moller DR. Involvement of T cells and alterations in T cell receptors in sarcoidosis. Semin. Respir. Infect.13(3), 174–183 (1998).
   PubMedGoogle Scholar
• Löfgren S. Erythema nodosum: studies on etiology and pathogenesis in 185 adult cases. Acta Med. Scand.124, 1–197 (1946).
   Google Scholar
• Caplan HI, Katz WA, Rubenstein M. Periarticular inflammation, bilateral hilar adenopathy and a sarcoid reaction. Arthritis Rheum.13(2), 101–111 (1970).
   PubMedGoogle Scholar
• Visser H, Vos K, Zanelli E et al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann. Rheum. Dis.61(6), 499–504 (2002).
   PubMedGoogle Scholar
• Grunewald J, Eklund A. Sex-specific manifestations of Lofgren’s syndrome. Am. J. Respir. Crit. Care Med.175(1), 40–44 (2007).
   PubMed Web of Science ®Google Scholar
• Mana J, Gomez-Vaquero C, Salazar A, Valverde J, Juanola X, Pujol R. Periarticular ankle sarcoidosis: a variant of Lofgren’s syndrome. J. Rheumatol.23(5), 874–877 (1996).
   PubMedGoogle Scholar
• Grunewald J. Clinical aspects and immune reactions in sarcoidosis. Clin. Respir. J.1, 64–73 (2007).
   PubMedGoogle Scholar
• Grunewald J, Brynedal B, Darlington P et al. Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir. Res.11, 25 (2010).
   PubMed Web of Science ®Google Scholar
• Baughman RP, Teirstein AS, Judson MA et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am. J. Respir. Crit. Care Med.164(10 Pt 1), 1885–1889 (2001).
   PubMed Web of Science ®Google Scholar
• Sato H, Woodhead FA, Ahmad T et al. Sarcoidosis HLA class 2 genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum. Mol. Genet.19(20), 4100–4111 (2010).
   PubMed Web of Science ®Google Scholar
• Ohta H, Tazawa R, Nakamura A et al. Acute-onset sarcoidosis with erythema nodosum and polyarthralgia (Löfgren’s syndrome) in Japan: a case report and a review of the literature. Intern. Med.45(9), 659–662 (2006).
   PubMed Web of Science ®Google Scholar
• Yanardag H, Pamuk ÖN, Karayel T. Löfgren syndrome in Turkey. Intern. Med. J.33, 535–537 (2003).
   PubMed Web of Science ®Google Scholar
• Mana J, Gomez-Vaquero C, Montero A et al. Löfgren’s syndrome revisited: a study of 186 patients. Am. J. Med.107(3), 240–245 (1999).
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Iannuzzi MC, Frederick MM et al. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am. J. Respir. Crit. Care Med.164(11), 2085–2091 (2001).
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Kirkey KL, Major M et al. Familial risk ratio of sarcoidosis in African–American sibs and parents. Am. J. Epidemiol.153(2), 188–193 (2001).
   PubMedGoogle Scholar
• Wiman LG. Familial occurrence of sarcoidosis. Scand. J. Respir. Dis. Suppl.80, 115–119 (1972).
   PubMedGoogle Scholar
• Sverrild A, Backer V, Kyvik KO et al. Heredity in sarcoidosis: a registry-based twin study. Thorax63(10), 894–896 (2008).
   PubMed Web of Science ®Google Scholar
• Judson MA, Hirst K, Iyengar SK et al. Comparison of sarcoidosis phenotypes among affected African–American siblings. Chest130(3), 855–862 (2006).
   PubMedGoogle Scholar
• Iannuzzi M, Rybicki B, Teirstein A. Medical progress: sarcoidosis. N. Engl. J. Med.357, 2153–2165 (2007).
   PubMed Web of Science ®Google Scholar
• Pietinalho A, Ohmichi M, Lofroos AB, Hiraga Y, Selroos O. The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases. Sarcoidosis Vasc. Diffuse Lung Dis.17(2), 158–166 (2000).
   PubMed Web of Science ®Google Scholar
• Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis Vasc. Diffuse Lung Dis.13(2), 159–166 (1996).
   PubMed Web of Science ®Google Scholar
• Schurmann M, Lympany PA, Reichel P et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am. J. Respir. Crit. Care Med.162(3 Pt 1), 861–864 (2000).
   PubMed Web of Science ®Google Scholar
• Hunninghake GW, Costabel U, Ando M et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and Other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis.16(2), 149–173 (1999).
   PubMed Web of Science ®Google Scholar
• Gardner J, Kennedy HG, Hamblin A, Jones E. HLA associations in sarcoidosis: a study of two ethnic groups. Thorax39(1), 19–22 (1984).
   PubMedGoogle Scholar
• Hedfors E, Lindstrom F. HLA-B8/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis. Tissue Antigens22(3), 200–203 (1983).
   PubMedGoogle Scholar
• Smith MJ, Turton CW, Mitchell DN, Turner-Warwick M, Morris LM, Lawler SD. Association of HLA B8 with spontaneous resolution in sarcoidosis. Thorax36(4), 296–298 (1981).
   PubMedGoogle Scholar
• Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am. J. Respir. Crit. Care Med.156(5), 1601–1605 (1997).
   PubMed Web of Science ®Google Scholar
• Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens57(1), 87–90 (2001).
   PubMedGoogle Scholar
• Grubic Z, Zunec R, Peros-Golubicic T et al. HLA class 1 and class 2 frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease. Tissue Antigens70(4), 301–306 (2007).
   PubMedGoogle Scholar
• Grunewald J, Eklund A, Olerup O. Human leukocyte antigen class 1 alleles and the disease course in sarcoidosis patients. Am. J. Respir. Crit. Care Med.169(6), 696–702 (2004).
   PubMed Web of Science ®Google Scholar
• Martinetti M, Tinelli C, Kolek V et al. ‘The sarcoidosis map’: a joint survey of clinical and immunogenetic findings in two European countries. Am. J. Respir. Crit. Care Med.152(2), 557–564 (1995).
   PubMedGoogle Scholar
• Mrazek F, Holla LI, Hutyrova B et al. Association of tumour necrosis factor-α, lymphotoxin-α and HLA-DRB1 gene polymorphisms with Löfgren’s syndrome in Czech patients with sarcoidosis. Tissue Antigens65(2), 163–171 (2005).
   PubMedGoogle Scholar
• Grunewald I, Eklund A. Specific bronchoalveolar lavage fluid T cells associate with disease in a pair of monozygotic twins discordant for sarcoidosis. J. Intern. Med.250(6), 535–539 (2001).
   PubMed Web of Science ®Google Scholar
• Fontenot AP, Torres M, Marshall WH, Newman LS, Kotzin BL. Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease. Proc. Natl Acad. Sci. USA97(23), 12717–12722 (2000).
   PubMed Web of Science ®Google Scholar
• Rossman MD, Kern JA, Elias JA et al. Proliferative response of bronchoalveolar lymphocytes to beryllium. A test for chronic beryllium disease. Ann. Intern. Med.108(5), 687–693 (1988).
   PubMed Web of Science ®Google Scholar
• Saltini C, Winestock K, Kirby M, Pinkston P, Crystal RG. Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells. N. Engl. J. Med.320(17), 1103–1109 (1989).
   PubMed Web of Science ®Google Scholar
• Falta MT, Bowerman NA, Dai S, Kappler JW, Fontenot AP. Linking genetic susceptibility and T cell activation in beryllium-induced disease. Proc. Am. Thorac. Soc.7(2), 126–129 (2010).
   PubMedGoogle Scholar
• Dai S, Murphy GA, Crawford F et al. Crystal structure of HLA-DP2 and implications for chronic beryllium disease. Proc. Natl Acad. Sci. USA107(16), 7425–7430 (2010).
   PubMedGoogle Scholar
• Foley PJ, McGrath DS, Puscinska E et al. Human leukocyte antigen-DRB1 position 11 residues are a common protective marker for sarcoidosis. Am. J. Respir. Cell Mol. Biol.25(3), 272–277 (2001).
   PubMed Web of Science ®Google Scholar
• Voorter CE, Amicosante M, Berretta F, Groeneveld L, Drent M, van den Berg-Loonen EM. HLA Class 2 amino acid epitopes as susceptibility markers of sarcoidosis. Tissue Antigens70(1), 18–27 (2007).
   PubMedGoogle Scholar
• Grunewald J, Eklund A. Studies of T-lymphocytes in pursuit of sarcoidosis antigens. Lakartidningen99(36), 3508–3513; 3515 (2002).
   PubMedGoogle Scholar
• Saltini C, Pallante M, Puxeddu E et al.M. avium binding to HLA-DR expressed alleles in silico: a model of phenotypic susceptibility to sarcoidosis. Sarcoidosis Vasc. Diffuse Lung Dis.25, 100–116 (2008).
   PubMedGoogle Scholar
• Thorsby E. HLA associated diseases. Hum. Immunol.53, 1–11 (1997).
   PubMed Web of Science ®Google Scholar
• Candore G, Modica MA, Lio D et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. Biomed. Pharmacother.57(7), 274–277 (2003).
   PubMedGoogle Scholar
• Sato H, Grutters JC, Pantelidis P et al.HLA-DQB1*0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am. J. Respir. Cell Mol. Biol.27(4), 406–412 (2002).
   PubMed Web of Science ®Google Scholar
• Rybicki BA, Maliarik MJ, Poisson LM et al. The major histocompatibility complex gene region and sarcoidosis susceptibility in African Americans. Am. J. Respir. Crit. Care Med.167(3), 444–449 (2003).
   PubMed Web of Science ®Google Scholar
• Valentonyte R, Hampe J, Huse K et al. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat. Genet.37(4), 357–364 (2005).
   PubMed Web of Science ®Google Scholar
• Li Y, Wollnik B, Pabst S et al.BTNL2 gene variant and sarcoidosis. Thorax61(3), 273–274 (2006).
   PubMed Web of Science ®Google Scholar
• Spagnolo P, Sato H, Grutters JC et al. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis. Tissue Antigens70(3), 219–227 (2007).
   PubMedGoogle Scholar
• Wijnen PA, Voorter CE, Nelemans PJ, Verschakelen JA, Bekers O, Drent M. Butyrophilin-like 2 in pulmonary sarcoidosis: a factor for susceptibility and progression? Hum. Immunol.72(4), 342–347 (2011).
   PubMed Web of Science ®Google Scholar
• Spagnolo P, Sato H, Grunewald J et al. A common haplotype of the C–C chemokine receptor 2 gene and HLA-DRB1*0301 are independent genetic risk factors for Löfgren’s syndrome. J. Intern. Med.264(5), 433–441 (2008).
   PubMed Web of Science ®Google Scholar
• Darlington P, Tallstedt L, Padyukov L et al.HLA-DRB1* alleles and symptoms associated with Heerfordt’s syndrome in sarcoidosis. Eur. Respir. J.38(5), 1151–1157 (2011).
   PubMed Web of Science ®Google Scholar
• Grunewald J, Eklund A. Lofgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am. J. Respir. Crit. Care Med.179(4), 307–312 (2009).
   PubMed Web of Science ®Google Scholar
• Bardinas F, Morera J, Fite E, Plasencia A. Seasonal clustering of sarcoidosis. Lancet2(8660), 455–456 (1989).
   PubMedGoogle Scholar
• Glennas A, Kvien TK, Melby K et al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br. J. Rheumatol.34(1), 45–50 (1995).
   PubMedGoogle Scholar
• Wilsher ML. Seasonal clustering of sarcoidosis presenting with erythema nodosum. Eur. Respir. J.12(5), 1197–1199 (1998).
   PubMed Web of Science ®Google Scholar
• Amicosante M, Puxeddu E, Saltini C. Reactivity to mycobacterial antigens by patients with Löfgren’s syndrome as a model of phenotypic susceptibility to disease and disease progression. Am. J. Respir. Crit. Care Med.180(7), 685 (2009).
   PubMedGoogle Scholar
• Moller DR, Konishi K, Kirby M, Balbi B, Crystal RG. Bias toward use of a specific T ell receptor β-chain variable region in a subgroup of individuals with sarcoidosis. J. Clin. Invest.82(4), 1183–1191 (1988).
   PubMed Web of Science ®Google Scholar
• Forrester JM, Wang Y, Ricalton N et al. TCR expression of activated T cell clones in the lungs of patients with pulmonary sarcoidosis. J. Immunol.153(9), 4291–4302 (1994).
   PubMed Web of Science ®Google Scholar
• Grunewald J, Eklund A. Role of CD4+ T cells in sarcoidosis. Proc. Am. Thorac. Soc.4(5), 461–464 (2007).
   PubMedGoogle Scholar
• Grunewald J, Wahlstrom J, Berlin M, Wigzell H, Eklund A, Olerup O. Lung restricted T cell receptor AV2S3+ CD4+ T cell expansions in sarcoidosis patients with a shared HLA-DRβ chain conformation. Thorax57(4), 348–352 (2002).
   PubMed Web of Science ®Google Scholar
• Dubaniewicz A. Mycobacterium tuberculosis heat shock proteins and autoimmunity in sarcoidosis. Autoimmun. Rev.9(6), 419–424 (2010).
   PubMed Web of Science ®Google Scholar
• Klareskog L, Stolt P, Lundberg K et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum.54(1), 38–46 (2006).
   PubMed Web of Science ®Google Scholar
• Wahlstrom J, Dengjel J, Persson B et al. Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J. Clin. Invest.117(11), 3576–3582 (2007).
   PubMed Web of Science ®Google Scholar
• Wahlström J, Dengjel J, Persson U et al. Autoimmune T-cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA-DR molecules in sarcoidosis. Clin. Immunol.133(3), 353–363 (2009).
   PubMedGoogle Scholar
• Wahlstrom J, Katchar K, Wigzell H, Olerup O, Eklund A, Grunewald J. Analysis of intracellular cytokines in CD4+ and CD8+ lung and blood T cells in sarcoidosis. Am. J. Respir. Crit. Care Med.163(1), 115–121 (2001).
   PubMed Web of Science ®Google Scholar
• Chen ES, Wahlstrom J, Song Z et al. T cell responses to mycobacterial catalase-peroxidase profile a pathogenic antigen in systemic sarcoidosis. J. Immunol.181(12), 8784–8796 (2008).
   PubMed Web of Science ®Google Scholar
• Song Z, Marzilli L, Greenlee BM et al. Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J. Exp. Med.201(5), 755–767 (2005).
   PubMed Web of Science ®Google Scholar